What we're reading, June 6, 2016: Vice President Joe Biden will announce the launch of an open-access cancer research database, and a new bill in Congress would allow companies to repurpose existing drugs for rare diseases.
An open-access cancer database for researchers will contain raw genomic and clinical data for 12,000 patients, initially. According to The Washington Post, the Genomic Data Commons will continue to add records as researchers contribute to it and will include data on the molecular makeup of cancers, which treatments were used and how the patients responded. Vice President Joe Biden, head of the Obama administration’s cancer moonshot initiative, has warned that research silos slow progress and that open access to data is critical.
A new bill in Congress would allow companies to repurpose existing drugs for rare diseases, which will be quicker and more economical that starting from scratch. The OPEN ACT (Orphan Product Extensions Now Accelerating Cures and Treatments) could potentially double the number of treatment options available to the 30 million Americans affected by 7000 rare diseases, according to an opinion piece published in The Seattle Times. With FDA oversight, the legislation would make therapies safely available to people who need them instead of prescribing therapies “off-label.”
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate
April 17th 2024A new study is among the largest real-world analyses to date to assess trends over time and predictive factors for older patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic cell transplantation (allo-HCT).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen